Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong · Delayed Price · Currency is HKD 3.960
+0.540 (15.79%)
At close: Apr 20, 2026
HKG:2427 Revenue
In the year 2025, Guanze Medical Information Industry (Holding) had annual revenue of 88.45M CNY, down -43.21%. Guanze Medical Information Industry (Holding) had revenue of 56.59M in the half year ending December 31, 2025, a decrease of -30.70%.
Revenue
88.45M CNY
Revenue Growth
-43.21%
P/S Ratio
38.22
Revenue / Employee
1.52M CNY
Employees
58
Market Cap
3.76B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 88.45M | -67.29M | -43.21% |
| Dec 31, 2024 | 155.74M | -332.00K | -0.21% |
| Dec 31, 2023 | 156.07M | -21.04M | -11.88% |
| Dec 31, 2022 | 177.11M | -33.96M | -16.09% |
| Dec 31, 2021 | 211.08M | 26.64M | 14.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 6.61B |
| Adicon Holdings | 2.94B |
| Kindstar Globalgene Technology | 1.04B |
| Yunkang Group | 669.23M |
| Mega Genomics | 275.03M |
| Biosino Bio-Technology and Science Incorporation | 205.08M |
| King International Investment | 77.50M |
| China Biotech Services Holdings | 73.50M |